Porous Fe 2 O 3 nanorods were obtained using a facile chemical solution method with subsequent calcination. The structures and morphological evolution were characterized by X-ray diffraction, field emission scanning electron microscopy, thermogravimetric-differential thermal analysis, and Brunauer-Emmett-Teller (BET) N 2 adsorption-desorption analyses. The calculated BET surface area of the porous Fe 2 O 3 nanorods was 18.8 m²·g -1 . The porous Fe 2 O 3 nanorods were used as a catalyst to photodegrade Rhodamine B, methylene blue, methyl orange, p-nitrophenol, and eosin B. Compared to the commercial Fe 2 O 3 powder, the as-prepared porous Fe 2 O 3 nanorods exhibited higher catalytic activities owing to their large surface areas and porous nanostructures. The photocatalytic reaction rate constant of the porous Fe 2 O 3 nanorods in the photocatalytic decomposition of Rhodamine B under simulated solar light was calculated to be 0.0131 min -1 .Moreover, the catalyst was found to have superior stability and reusability.

No abstract

No abstract

Background: Diffuse large B-cell lymphoma used to be defined as germinal center B-like and non-germinal center B-like subtypes, associated with different prognoses, but the conventional classification does not meet the needs of clinical practice because of diffuse large B-cell lymphoma heterogeneity, a problem that might be improved by selection of miRNAs as biomarkers. Methods: Twelve patients with diffuse large B-cell lymphomas were used to screen out the aberrant miRNA profile using miRNA microarray technology in 2 patient subtypes (6 germinal center B-like and 6 non-germinal center B-like patients). The potential biomarkers were further analyzed using the quantitative reverse transcription-polymerase chain reaction method in 95 diffuse large B-cell lymphoma patients to investigate relationships between expression levels of potent miRNA, clinicopathological features, and survival rates of patients. Results: miR-208a-5p, miR-296-5p and miR-1304-5p were screened as potential biomarkers. miR-208a-5p and miR-296-5p were shown to be associated with better survival of patients after Kaplan-Meier analysis, whereas miR-1304-5p overexpression indicated a poor survival prognosis independent of the diffuse large B-cell lymphoma subtype. In addition, changes of miR-296-5p and miR-1304-5p expression, the International Prognostic Index status and the age of patients were all independent indicators for diffuse large B-cell lymphoma prognosis. We also found that high miR-208a-5p expression led to better outcomes in diffuse large B-cell lymphoma patients with similar International Prognostic Index scores; however high miR-1304-5p expression tended to indicate the opposite. Conclusions: MiR-208a-5p, miR-296-5p and miR-1304-5p levels might be potential biomarkers for the prediction of the prognosis of diffuse large B-cell lymphoma patients.